Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
9.90
+0.10 (1.02%)
At close: Dec 3, 2025

Silva Pharmaceuticals Ratios and Metrics

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
1,3511,4611,9522,9483,2902,689
Upgrade
Market Cap Growth
-2.94%-25.17%-33.80%-10.37%22.34%7.65%
Upgrade
Enterprise Value
1,2611,3621,8202,8133,1322,480
Upgrade
Last Close Price
9.9010.7014.1621.2923.4218.63
Upgrade
PE Ratio
---89.1432.1722.44
Upgrade
PS Ratio
3.643.813.264.114.223.36
Upgrade
PB Ratio
0.650.690.871.261.421.18
Upgrade
P/TBV Ratio
0.650.690.871.261.421.19
Upgrade
P/FCF Ratio
66.29225.07---32.71
Upgrade
P/OCF Ratio
55.68107.73570.9442.0620.4516.87
Upgrade
EV/Sales Ratio
3.403.553.043.924.023.10
Upgrade
EV/EBITDA Ratio
--157.0826.2217.9611.96
Upgrade
EV/EBIT Ratio
---62.8228.0217.45
Upgrade
EV/FCF Ratio
61.86209.82---30.16
Upgrade
Debt / Equity Ratio
0.020.020.020.030.040.02
Upgrade
Debt / EBITDA Ratio
--3.950.560.550.20
Upgrade
Debt / FCF Ratio
1.524.87---0.52
Upgrade
Asset Turnover
0.160.160.240.280.310.33
Upgrade
Inventory Turnover
0.620.610.891.001.041.07
Upgrade
Quick Ratio
5.685.975.175.113.766.13
Upgrade
Current Ratio
13.5214.9012.6711.617.7012.15
Upgrade
Return on Equity (ROE)
-6.32%-6.09%-2.81%1.42%4.45%5.36%
Upgrade
Return on Assets (ROA)
-3.34%-3.22%-1.20%1.11%2.80%3.62%
Upgrade
Return on Capital (ROIC)
-3.51%-3.38%-1.25%1.16%2.95%3.90%
Upgrade
Return on Capital Employed (ROCE)
-5.70%-5.50%-2.00%1.90%4.60%6.00%
Upgrade
Earnings Yield
-10.06%-9.10%-3.30%1.12%3.11%4.46%
Upgrade
FCF Yield
1.51%0.44%-1.52%-0.57%-0.51%3.06%
Upgrade
Dividend Yield
1.02%-0.71%0.47%1.28%2.68%
Upgrade
Payout Ratio
---75.66%46.70%39.46%
Upgrade
Total Shareholder Return
1.02%-0.71%0.47%1.28%2.68%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.